Labcorp Board Approves $0.72 Quarterly Dividend Payable September 11
LH•Labcorp’s board declared a quarterly cash dividend of $0.72 per share, payable September 11, 2026, to shareholders of record on August 28, 2026. The company’s 71,000 employees across nearly 100 countries supported over 85% of FDA-approved drugs in 2025 and performed more than 750 million tests, underpinning its cash flow.
1. Dividend Declaration and Schedule
Labcorp’s board has approved a quarterly cash dividend of $0.72 per share, with a record date of August 28, 2026 and a payment date of September 11, 2026. This distribution reflects the company’s ongoing commitment to returning capital to shareholders.
2. Operational Scale and Cash Generation
The company employs nearly 71,000 people in about 100 countries and conducted over 750 million diagnostic tests last year. It supported more than 85% of new drugs approved by the FDA in 2025, highlighting robust lab service demand that fuels its cash flow and dividend capacity.
